Colton Wickham, MBA, CPA, currently serves as the Global Finance Lead for the Biosimilar Business Unit at Amgen from June 2023 to August 2025, focusing on portfolio analytics and strategy. Previously at Amgen, Colton held multiple managerial roles within the Finance & Strategy Leadership Development Program, including positions in R&D Finance and Intercontinental Region FP&A. Colton earned an MBA from Duke University - The Fuqua School of Business, where achievements included being a University Scholars Graduate Fellow and a recipient of the Bovender Family/HCA Scholarship. Prior experience includes serving as Treasurer on the Board of Directors for the Youth Mentoring Action Network and working as an Assurance Services Senior at EY. Colton holds a Bachelor of Business Administration in Accounting from California State University-Long Beach.
This person is not in the org chart
This person is not in any teams
This person is not in any offices